ANXA2 and hepatocellular carcinoma: The immunoassay demonstrated high accuracy for the detection of ANXA2 in serum samples from hepatocellular carcinoma patients, with a wide range of ANXA2 concentrations (100 fg/mL-100 ng/mL) covered (Figure S17D) [260].